help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ritzel, R. A.
Right arrow Articles by Butler, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ritzel, R. A.
Right arrow Articles by Butler, P. C.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 2 795-805
Copyright © 2004 by The Endocrine Society

Induction of ß-Cell Rest by a Kir6.2/SUR1-Selective KATP-Channel Opener Preserves ß-Cell Insulin Stores and Insulin Secretion in Human Islets Cultured at High (11 mM) Glucose

Robert A. Ritzel, John B. Hansen, Johannes D. Veldhuis and Peter C. Butler

Division of Endocrinology and Diabetes, Keck School of Medicine, University of Southern California (R.A.R., P.C.B.), Los Angeles, California 90033; Medicinal Chemistry, Research and Development, Novo Nordisk A/S (J.B.H.), DK 2760, Måløv, Denmark; and Endocrine Division, Mayo Medical and Graduate Schools of Medicine, Mayo Clinic (J.D.V.), Rochester, Minnesota 55905

Address all correspondence and requests for reprints to: Peter C. Butler, M.D., Division of Endocrinology and Diabetes, Keck School of Medicine, University of Southern California, 1333 San Pablo Street, BMT-B11, Los Angeles, California 90033. E-mail: pbutler{at}usc.edu.

In health, most insulin is secreted in pulses. Type 2 diabetes mellitus (TTDM) is characterized by impaired pulsatile insulin secretion with a defect in insulin pulse mass. It has been suggested that this defect is partly due to chronic overstimulation of ß-cells imposed by insulin resistance and hyperglycemia, which results in depletion of pancreatic insulin stores. It has been reported that in TTDM overnight inhibition of insulin secretion (induction of ß-cell rest) leads to quantitative normalization of pulsatile insulin secretion upon subsequent stimulation. Recently, decreased orderliness of insulin secretion has been recognized as another attribute of impaired insulin secretion in TTDM. In the current studies we sought to address at the level of the isolated islet whether chronic elevated glucose concentrations induce both defects involved in impaired insulin secretion in TTDM: deficiency and decreased orderliness of insulin secretion. We use the concept of ß-cell rest, induced by a novel ß-cell selective KATP-channel opener (KCO), NN414 (6-chloro-3-(1-methylcyclopropyl)amino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide), to test whether preservation of insulin stores leads to normalization of both processes in response to glucose stimulation. Human islets were isolated from three cadaveric organ donors and studied in perifusion experiments and static incubation. Acute activation of KATP-channels suppressed insulin secretion from perifused human islets by ~90% (P < 0.0001). This KCO also inhibited glucagon secretion in a dose-dependent manner (P = 0.01). Static incubation at 11 and 16 vs. 4 mM glucose for 96 h decreased islet insulin stores by approximately 80% and 85% (P < 0.0001, respectively). In subsequent perifusion experiments, total insulin secretion (~30%; P < 0.01) from these islets and insulin pulse mass (~40%; P < 0.05) were both decreased (11 vs. 4 mM). The inhibition of insulin secretion during static incubation with KCO reduced the loss of islet insulin stores in a dose-dependent manner (P < 0.0001) and resulted in increased total insulin secretion (2.6-fold; P < 0.01) and insulin pulse mass (2.5-fold; P < 0.05) during subsequent perifusion. The orderliness of insulin secretion was significantly reduced after chronic incubation of human islets at 11 mM glucose (P = 0.04), but induction of ß-cell rest at 11 mM failed to normalize the regularity of insulin secretion during subsequent perifusion. We conclude that physiological increased glucose concentrations (11 mM), which are frequently observed in diabetes, lead to a loss of islet insulin stores and defective pulsatile insulin secretion as well as reduced orderliness of insulin secretion. Induction of ß-cell rest by selective activation of ß-cell KATP-channels preserves insulin stores and pulsatile insulin secretion without restoring the orderliness of insulin secretion. Therefore, the concept of ß-cell rest may provide a strategy to protect ß-cells from chronic overstimulation and to improve islet function. Impaired glucose-regulated insulin secretion in TTDM may, however, partially involve mechanisms that are distinct from insulin stores and insulin secretion rates.

This work was supported in part by the Deutsche Forschungsgemeinschaft (Ri 1055), the NIH (DK-61539), and the Hillblom Foundation.

Abbreviations: ApEn, Approximate entropy; KCO, KATP-channel opener; KRB, Krebs-Ringer-bicarbonate; TTDM, type 2 diabetes mellitus.




This article has been cited by other articles:


Home page
Diabetes CareHome page
M. Y. Donath, D. M. Schumann, M. Faulenbach, H. Ellingsgaard, A. Perren, and J. A. Ehses
Islet Inflammation in Type 2 Diabetes: From metabolic stress to therapy
Diabetes Care, February 1, 2008; 31(Supplement_2): S161 - S164.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. Ng, Y. Kang, C. L. Elias, Y. He, H. Xie, J. B. Hansen, P. Wahl, and H. Y. Gaisano
The Actions of a Novel Potent Islet {beta}-Cell Specific ATP-Sensitive K+ Channel Opener Can Be Modulated by Syntaxin-1A Acting on Sulfonylurea Receptor 1
Diabetes, August 1, 2007; 56(8): 2124 - 2134.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. J. Michael, W. Xiong, X. Geng, P. Drain, and R. H. Chow
Human Insulin Vesicle Dynamics During Pulsatile Secretion
Diabetes, May 1, 2007; 56(5): 1277 - 1288.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. L. Wajchenberg
{beta}-Cell Failure in Diabetes and Preservation by Clinical Treatment
Endocr. Rev., April 1, 2007; 28(2): 187 - 218.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
W. El-Kholy, P. E. MacDonald, J. M. Fox, A. Bhattacharjee, T. Xue, X. Gao, Y. Zhang, J. Stieber, R. A. Li, R. G. Tsushima, et al.
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels in Pancreatic {beta}-Cells
Mol. Endocrinol., March 1, 2007; 21(3): 753 - 764.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Buteau, A. Shlien, S. Foisy, and D. Accili
Metabolic Diapause in Pancreatic beta-Cells Expressing a Gain-of-function Mutant of the Forkhead Protein Foxo1
J. Biol. Chem., January 5, 2007; 282(1): 287 - 293.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. V. Matveyenko, J. D. Veldhuis, and P. C. Butler
Mechanisms of impaired fasting glucose and glucose intolerance induced by a ~50% pancreatectomy.
Diabetes, August 1, 2006; 55(8): 2347 - 2356.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. A. Ritzel, J. D. Veldhuis, and P. C. Butler
The mass, but not the frequency, of insulin secretory bursts in isolated human islets is entrained by oscillatory glucose exposure
Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E750 - E756.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. A. Ritzel, A. E. Butler, R. A. Rizza, J. D. Veldhuis, and P. C. Butler
Relationship Between {beta}-Cell Mass and Fasting Blood Glucose Concentration in Humans.
Diabetes Care, March 1, 2006; 29(3): 717 - 718.
[Full Text] [PDF]


Home page
DiabetesHome page
M. Y. Donath, J. A. Ehses, K. Maedler, D. M. Schumann, H. Ellingsgaard, E. Eppler, and M. Reinecke
Mechanisms of {beta}-Cell Death in Type 2 Diabetes
Diabetes, December 1, 2005; 54(suppl_2): S108 - S113.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
M. Zdravkovic, M. Kruse, K. L. Rost, J. Moss, A. Kecskes, and T. Dyrberg
The Effects of NN414, a SUR1/Kir6.2 Selective Potassium Channel Opener, in Healthy Male Subjects
J. Clin. Pharmacol., July 1, 2005; 45(7): 763 - 772.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. Maedler, J. Storling, J. Sturis, R. A. Zuellig, G. A. Spinas, P. O.G. Arkhammar, T. Mandrup-Poulsen, and M. Y. Donath
Glucose- and Interleukin-1{beta}-Induced {beta}-Cell Apoptosis Requires Ca2+ Influx and Extracellular Signal-Regulated Kinase (ERK) 1/2 Activation and Is Prevented by a Sulfonylurea Receptor 1/Inwardly Rectifying K+ Channel 6.2 (SUR/Kir6.2) Selective Potassium Channel Opener in Human Islets
Diabetes, July 1, 2004; 53(7): 1706 - 1713.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society